The Latest

A Cheaper Alternative to Truvada Is Hitting the Market: Here's Why It Might Not Lower Costs

Barring the unlikely event that a U.S. entity puts time and money into comparative trials, Cimduo can't cut into the PrEP portion of the Truvada market.

By Tim Murphy